Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
ClinicalTrials.gov Identifier: NCT04327401.
Publications
View AllEvaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials
Our findings support that changes in plasma p-tau217 represent a robust endpoint for clinical trials targeting CU or CI individuals with Aβ pathology.
Affiliated Researchers
Institution Info
- Type
- healthcare
- Country
- BR
- Publications
- 2
- Citations
- 1,257
External Links
Identifiers
- ROR
- https://ror.org/009gqrs30